Immunohistochemical localization of receptor for advanced glycation end (RAGE) products in the R6/2 mouse model of Huntington's disease

Brain Research Bulletin

Volumn 87, Issue 2-3, 2012, Pages 350-358

  Anzilotti, Serenella ^a   Giampà, Carmela ^a   Laurenti, Daunia ^a   Perrone, Lorena ^b   Bernardi, Giorgio ^a,c   Melone, Mariarosa A B ^d   Fusco, Francesca R ^a  

^a IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^b Mediterranée University   (France)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

^d SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Confocal microscopy; Huntington's disease; Immunohistochemistry; R6 2; RAGE

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; PARVALBUMIN; SOMATOSTATIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLINERGIC NERVE CELL; CONTROLLED STUDY; CORPUS STRIATUM; CYTOPLASM; HUNTINGTON CHOREA; IMMUNOHISTOCHEMISTRY; IMMUNOLOCALIZATION; IMMUNOREACTIVITY; INTERNEURON; MALE; MOUSE; NERVE CELL; NERVE DEGENERATION; NEUROPIL; NONHUMAN; PARVALBUMIN INTERNEURON; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SOMATOSTATIN INTERNEURON; STRIATE CORTEX; UPREGULATION; WILD TYPE;

ANALYSIS OF VARIANCE; ANIMALS; CALCIUM-BINDING PROTEIN, VITAMIN D-DEPENDENT; CELL COUNT; CHOLINESTERASES; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; HUMANS; HUNTINGTON DISEASE; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MUTATION; NERVE TISSUE PROTEINS; NEURONS; PARVALBUMINS; PHOSPHOPYRUVATE HYDRATASE; RECEPTORS, IMMUNOLOGIC; SOMATOSTATIN;

EID: 84856590656     PISSN: 03619230     EISSN: 18732747     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2011.01.009     Document Type: Article

References (36)

1. Apicella P. Leading tonically active neurons of the striatum from reward detection to context recognition. Trends Neurosci. 2007, 30:299-306.
2. Aznavour N., et al. Fine structural features of the acetylcholine innervation in the developing neostriatum of rat. J. Comp. Neurol. 2003, 460:280-291.
3. Bolam J.P., Wainer B.H., Smith A.D. Characterization of cholinergic neurons in the rat neostriatum. A combination of choline acetyltransferase immunocytochemistry, Golgi-impregnation and electron microscopy. Neuroscience 1984, 12:711-718.
4. Donato R., Sorci G., Riuzzi F., Arcuri C., Bianchi R., Brozzi F., Tubaro C., Giambanco I. S100B's double life: intracellular regulator and extracellular signal. Biochim. Biophys. Acta 2009, 1793:1008-1022.
5. Fusco F.R., Chen Q., Lamoreaux W.J., Figueredo-Cardenas G., Jiao Y., Coffman J.A., Surmeier D.J., Honig M.G., Carlock L.R., Reiner A. Cellular localization of huntingtin in striatal and cortical neurons in rats: lack of correlation with neuronal vulnerability in Huntington's disease. J. Neurosci. 1999, 19:1189-1202.
6. Fusco F.R., Viscomi M.T., Bernardi G., Molinari M. Localization of ataxin-2 within the cerebellar cortex of the rat. Brain Res. Bull. 2001, 56:343-347.
7. Fusco F.R., Martorana A., De March Z., Viscomi M.T., Sancesario G., Bernardi G. Huntingtin distribution among striatal output neurons of normal rat brain. Neurosci. Lett. 2003, 339:53-56.
8. Giampa C., Patassini S., Borreca A., Laurenti D., Marullo F., Bernardi G., Menniti F.S., Fusco F.R. Phosphodiesterase 10 inhibition reduces striatal excitotoxicity in the quinolinic acid model of Huntington's disease. Neurobiol. Dis. 2009, 34:450-456.
9. Graveland G.A., DiFiglia M. The frequency and distribution of medium-sized neurons with indented nuclei in the primate and rodent neostriatum. Brain Res. 1985, 327:307-311.
10. Graveland G.A., et al. Evidence for degenerative and regenerative changes in neostriatal spiny neurons in Huntington's disease. Science 1985, 227:770-773.
11. Griffin W.S., Yeralan O., Sheng J.G., Boop F.A., Mrak R.E., Rovnaghi C.R., Burnett B.A., Feoktistova A., Van Eldik L.J. Overexpression of the neurotrophic cytokine S100 beta in human temporal lobe epilepsy. J. Neurochem. 1995, 65:228-233.
12. Hoffmann K., Sivukhina E., Potschka H., Schachner M., Loscher W., Dityatev A. Retarded kindling progression in mice deficient in the extracellular matrix glycoprotein tenascin-R. Epilepsia 2009, 50:859-869.
13. Hori O., Brett J., Slattery T., Cao R., Zhang J., Chen J.X., Nagashima M., Lundh E.R., Vijay S., Nitecki D., et al. The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system. J. Biol. Chem. 1995, 270:25752-25761.
14. Kim M.H., Choi Y.W., Choi H.Y., Myung K.B., Cho S.N. The expression of RAGE and EN-RAGE in leprosy. Br. J. Dermatol. 2006, 154:594-601.
15. Kosinski C.M., Cha J.H., Young A.B., Persichetti F., MacDonald M., Gusella J.F., Penney J.B., Standaert D.G. Huntingtin immunoreactivity in the rat neostriatum: differential accumulation in projection and interneurons. Exp. Neurol. 1997, 144:239-247.
16. Lue L.F., Walker D.G., Brachova L., Beach T.G., Rogers J., Schmidt A.M., Stern D.M., Yan S.D. Involvement of microglial receptor for advanced glycation endproducts (RAGE) in Alzheimer's disease: identification of a cellular activation mechanism. Exp. Neurol. 2001, 171:29-45.
17. Ma L., Nicholson L.F. Expression of the receptor for advanced glycation end products in Huntington's disease caudate nucleus. Brain Res. 2004, 1018:10-17.
18. Miller M.C., Tavares R., Johanson C.E., Hovanesian V., Donahue J.E., Gonzalez L., Silverberg G.D., Stopa E.G. Hippocampal RAGE immunoreactivity in early and advanced Alzheimer's disease. Brain Res. 2008, 1230:273-280.
19. Neeper M., Schmidt A.M., Brett J., Yan S.D., Wang F., Pan Y.C., Elliston K., Stern D., Shaw A. Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. J. Biol. Chem. 1992, 267:14998-15004.
20. Perrone L., Peluso G., Melone M.A. RAGE recycles at the plasma membrane in S100B secretory vesicles and promotes Schwann cells morphological changes. J. Cell. Physiol. 2008, 217:60-71.
21. Perrone L., Devi T.S., Hosoya K., Terasaki T., Singh L.P. Thioredoxin interacting protein (TXNIP) induces inflammation through chromatin modification in retinal capillary endothelial cells under diabetic conditions. J. Cell. Physiol. 2009, 221:262-272.
22. Sasaki N., Toki S., Chowei H., Saito T., Nakano N., Hayashi Y., Takeuchi M., Makita Z. Immunohistochemical distribution of the receptor for advanced glycation end products in neurons and astrocytes in Alzheimer's disease. Brain Res. 2001, 888:256-262.
23. Sasaki N., Takeuchi M., Chowei H., Kikuchi S., Hayashi Y., Nakano N., Ikeda H., Yamagishi S., Kitamoto T., Saito T., Makita Z. Advanced glycation end products (AGE) and their receptor (RAGE) in the brain of patients with Creutzfeldt-Jakob disease with prion plaques. Neurosci. Lett. 2002, 326:117-120.
24. Schmidt A.M., Hori O., Chen J.X., Li J.F., Crandall J., Zhang J., Cao R., Yan S.D., Brett J., Stern D. Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of diabetes. J. Clin. Invest. 1995, 96:1395-1403.
25. Schmidt A.M., Hori O., Cao R., Yan S.D., Brett J., Wautier J.L., Ogawa S., Kuwabara K., Matsumoto M., Stern D. RAGE: a novel cellular receptor for advanced glycation end products. Diabetes 1996, 45(Suppl. 3):S77-S80.
26. Schmidt A.M., Hofmann M., Taguchi A., Yan S.D., Stern D.M. RAGE: a multiligand receptor contributing to the cellular response in diabetic vasculopathy and inflammation. Semin. Thromb. Hemost. 2000, 26:485-493.
27. Schmidt A.M., Yan S.D., Yan S.F., Stern D.M. The biology of the receptor for advanced glycation end products and its ligands. Biochim. Biophys. Acta 2000, 1498:99-111.
28. Sharp A.H., Ross C.A. Neurobiology of Huntington's disease. Neurobiol. Dis. 1996, 3:3-15.
29. Smith R., Chung H., Rundquist S., Maat-Schieman M.L., Colgan L., Englund E., Liu Y.J., Roos R.A., Faull R.L., Brundin P., Li J.Y. Cholinergic neuronal defect without cell loss in Huntington's disease. Hum. Mol. Genet. 2006, 15:3119-3131.
30. Takuma K., Fang F., Zhang W., Yan S., Fukuzaki E., Du H., Sosunov A., McKhann G., Funatsu Y., Nakamichi N., Nagai T., Mizoguchi H., Ibi D., Hori O., Ogawa S., Stern D.M., Yamada K., Yan S.S. RAGE-mediated signaling contributes to intraneuronal transport of amyloid-beta and neuronal dysfunction. Proc. Natl. Acad. Sci. U. S. A. 2009, 106(47):20021-20026.
31. Tohgi H., Utsugisawa K., Nagane Y., Yoshimura M., Ukitsu M., Genda Y. Decrease with age in methylcytosines in the promoter region of receptor for advanced glycated end products (RAGE) gene in autopsy human cortex. Brain Res. Mol. Brain Res. 1999, 65:124-128.
32. Vincent A.M., Perrone L., Sullivan K.A., Backus C., Sastry A.M., Lastoskie C., Feldman E.L. Receptor for advanced glycation end products activation injures primary sensory neurons via oxidative stress. Endocrinology 2007, 148:548-558.
33. Woolf N.J., Butcher L.L. Cholinergic neurons in the caudate-putamen complex proper are intrinsically organized: a combined Evans blue and acetylcholinesterase analysis. Brain Res. Bull. 1981, 7:487-507.
34. Yan S.D., Chen X., Fu J., Chen M., Zhu H., Roher A., Slattery T., Zhao L., Nagashima M., Morser J., Migheli A., Nawroth P., Stern D., Schmidt A.M. RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease. Nature 1996, 382:685-691.
35. Yan S.D., Stern D., Schmidt A.M. What's the RAGE? The receptor for advanced glycation end products (RAGE) and the dark side of glucose. Eur. J. Clin. Invest. 1997, 27:179-181.
36. Zhou F.M., Wilson C.J., Dani J.A. Cholinergic interneuron characteristics and nicotinic properties in the striatum. J. Neurobiol. 2002, 53:590-605.